{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:17:48Z","timestamp":1783577868773,"version":"3.55.0"},"reference-count":259,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In the last decades, colorectal cancer (CRC) has emerged as a global problem, representing approximately 10% of all malignant tumors and the second leading cause of cancer-related death. Colitis-associated cancer (CAC) arises from chronic unresolved inflammation and is typically characterised by poor prognosis. Among key cellular regulators, the small GTPase RHOA controls cytoskeleton dynamics in various cell types and, thereby, key biological processes. Although it has been linked to various diseases, the role of RHOA in cancer remains controversial. RHOA has been proposed as a biomarker in cancer including CRC, but recent evidence shows that RHOA inactivation increases Wnt signalling and tumour risk in the murine intestinal epithelium. This review summarises the mechanisms of RHOA function and regulation and analyses the oncogenic pathways in which it is involved, with a focus on sporadic CRC and CAC. We discuss whether the RHOA pathway serves the same function in the two types of intestinal cancer and how the inflammatory context can modulate RHOA outcome following activation or inhibition, which still remains an open question. Finally, we address opportunities for therapeutic targeting of RHOA and related proteins. The understanding of the function of RHOA specifically in CRC may help identify limitations that might have hampered the development of novel targets for optimized treatment and\/or diagnostic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1844372","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:49Z","timestamp":1783575289000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["RHOA at the intersection of inflammation-driven and sporadic colorectal cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Sofia Elena","family":"Muccioli","sequence":"first","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"Deutsches Zentrum Immuntherapie","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hidalgo-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"Deutsches Zentrum Immuntherapie","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong A","family":"Ngo","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"Deutsches Zentrum Immuntherapie","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F","family":"Neurath","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"Deutsches Zentrum Immuntherapie","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"L\u00f3pez-Posadas","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"Deutsches Zentrum Immuntherapie","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000004428","article-title":"Global, regional, and national burdens of colorectal cancer and inflammatory bowel disease 1990-2021 and projections to 2050: a cross-sectional study","volume":"112","author":"Zhang","year":"2026","journal-title":"Int J Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.08.033","article-title":"Epithelial-mesenchymal transition","volume":"188","author":"Zhang","year":"2025","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-026-02970-y","article-title":"Statistics and epidemiology of inflammatory bowel disease-associated colorectal neoplasia","volume":"31","author":"Shinagawa","year":"2026","journal-title":"Int J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.12.011","article-title":"The molecular landscape of colitis-associated carcinogenesis","volume":"49","author":"Saraggi","year":"2017","journal-title":"Dig Liver Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1247106","article-title":"Digital spatial profiling identifies molecular changes involved in development of colitis-associated colorectal cancer","volume":"14","author":"Glyn","year":"2024","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156249","article-title":"From inflammation to carcinogenesis: distinct pathways and clinical implications of IBD-associated colorectal cancer compared with sporadic CRC","volume":"275","author":"Kapadia","year":"2025","journal-title":"Pathol Res Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.036","article-title":"Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers","volume":"150","author":"Robles","year":"2016","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/jci80997","article-title":"Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation","volume":"126","author":"Lopez-Posadas","year":"2016","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.01.030","article-title":"Canonical and noncanonical Wnt signaling: multilayered mediators, signaling mechanisms and major signaling crosstalk","volume":"11","author":"Qin","year":"2024","journal-title":"Genes Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-29-123","article-title":"Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo","volume":"29","author":"Wang","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"109400","DOI":"10.1016\/j.isci.2024.109400","article-title":"RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis","volume":"27","author":"Dopeso","year":"2024","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1038\/ncomms6458","article-title":"RHOA inactivation enhances Wnt signalling and promotes colorectal cancer","volume":"5","author":"Rodrigues","year":"2014","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13046-018-1014-x","article-title":"CXCL12\/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p","volume":"38","author":"Yu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.3281","article-title":"RhoA is associated with invasion and poor prognosis in colorectal cancer","volume":"48","author":"Jeong","year":"2016","journal-title":"Int J Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0963-7","article-title":"Rho GTPases in cancer: friend or foe","volume":"38","author":"Svensmark","year":"2019","journal-title":"Oncogene"},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s1470-2045(24)00600-4","article-title":"Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data","volume":"26","author":"Sung","year":"2025","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)01221-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.126","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v15.i8.1317","article-title":"Update and latest advances in mechanisms and management of colitis-associated colorectal cancer","volume":"15","author":"Dan","year":"2023","journal-title":"World J Gastrointest Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41389-023-00492-0","article-title":"Molecular mechanisms in colitis-associated colorectal cancer","volume":"12","author":"Zhou","year":"2023","journal-title":"Oncogenesis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-026-01197-6","article-title":"Pathophysiology of colitis-associated colorectal cancer","volume":"23","author":"Neufert","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1165326","article-title":"Uncoupled nitric oxide synthase activity promotes colorectal cancer progression","volume":"13","author":"Alam","year":"2023","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12967-025-06583-3","article-title":"Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches","volume":"23","author":"Bakrim","year":"2025","journal-title":"J Transl Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.14.1062","article-title":"Blocking oncogenic Ras signaling for cancer therapy","volume":"93","author":"Adjei","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.04.001","article-title":"Genomic alterations observed in colitis-associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease","volume":"151","author":"Yaeger","year":"2016","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12957-018-1428-0","article-title":"Genomic characterization of colitis-associated colorectal cancer","volume":"16","author":"Kameyama","year":"2018","journal-title":"World J Surg Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4561","article-title":"Management of colorectal cancer","volume":"366","author":"Brown","year":"2019","journal-title":"BMJ"},{"key":"B30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","article-title":"Current and emerging therapeutic approaches for colorectal cancer: a comprehensive review","volume":"15","author":"Kumar","year":"2023","journal-title":"World J Gastrointest Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01624","article-title":"Colorectal cancer immunotherapy: options and strategies","volume":"11","author":"Johdi","year":"2020","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.835256","article-title":"Molecular endoscopy for the diagnosis and therapeutic monitoring of colorectal cancer","volume":"12","author":"Waldner","year":"2022","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/ijc.32055","article-title":"Global trends in colorectal cancer mortality: projections to the year 2035","volume":"144","author":"Araghi","year":"2019","journal-title":"Int J Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12964-024-01856-8","article-title":"Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas","volume":"22","author":"Dregelies","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-416749-0.00001-4","article-title":"The ras superfamily G-proteins","volume":"33","author":"Tetlow","year":"2013","journal-title":"Enzymes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-62703-791-4_1","article-title":"The Ras superfamily of small GTPases: the unlocked secrets","volume":"1120","author":"Goitre","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1134\/s1990519x24700159","article-title":"Role of rho family small GTPases in the regulation of normal and pathological processes","volume":"18","author":"Bobkov","year":"2024","journal-title":"Cell Tissue Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","article-title":"Rho GTPase signaling in cancer progression and dissemination","volume":"102","author":"Crosas-Molist","year":"2022","journal-title":"Physiol Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/febs.15453","article-title":"Rab family of small GTPases: an updated view on their regulation and functions","volume":"288","author":"Homma","year":"2021","journal-title":"FEBS J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1021\/acscatal.5c00719","article-title":"Mechanistic insights into GTP hydrolysis by the RhoA protein: catalytic impact of glutamine tautomerism","volume":"15","author":"Pardos","year":"2025","journal-title":"ACS Catal"},{"key":"B42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/cells10010066","article-title":"Rho GTPases as key molecular players within intestinal mucosa and GI diseases","volume":"10","author":"Pradhan","year":"2021","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40164-022-00344-4","article-title":"RHO GTPase family in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14578","article-title":"RhoA regulation in space and time","volume":"597","author":"de Seze","year":"2023","journal-title":"FEBS Lett"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114915","article-title":"Regulation of protein prenylation","volume":"164","author":"Jung","year":"2023","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-024-01759-7","article-title":"Protein lipidation in health and disease: Molecular basis, physiological function and pathological implication","volume":"9","author":"Yuan","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B47","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.3390\/ijms222212493","article-title":"Electrostatic forces mediate the specificity of RHO GTPase-GDI interactions","volume":"22","author":"Mosaddeghzadeh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/cells8091037","article-title":"Regulation of rho GTPases by rhoGDIs in human cancers","volume":"8","author":"Cho","year":"2019","journal-title":"Cells"},{"key":"B49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00018-022-04618-2","article-title":"Rho family GTPase signaling through type II p21-activated kinases","volume":"79","author":"Chetty","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/genes14020272","article-title":"Effect of the Rho-Kinase\/ROCK signaling pathway on cytoskeleton components","volume":"14","author":"Guan","year":"2023","journal-title":"Genes"},{"key":"B51","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1038\/s41467-025-64635-0","article-title":"A Rho GTPase-effector ensemble governs cell migration behavior","volume":"16","author":"Lee","year":"2025","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(17)32124-5","article-title":"A cardiolipin-activated protein kinase from rat liver structurally distinct from the protein kinases C","volume":"269","author":"Morrice","year":"1994","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.72.121801.161742","article-title":"Biology of the p21-activated kinases","volume":"72","author":"Bokoch","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4161\/sgtp.28003","article-title":"P21 activated kinases: structure, regulation, and functions","volume":"5","author":"Rane","year":"2014","journal-title":"Small GTPases"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.3390\/ijms26083885","article-title":"The role of the p21-activated kinase family in tumor immunity","volume":"26","author":"Lu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-14-0827","article-title":"Molecular pathways: targeting the kinase effectors of RHO-family GTPases","volume":"21","author":"Prudnikova","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00222","article-title":"Targeting rho GTPase signaling networks in cancer","volume":"8","author":"Clayton","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/cells10071831","article-title":"The RHO family GTPases: mechanisms of regulation and signaling","volume":"10","author":"Mosaddeghzadeh","year":"2021","journal-title":"Cells"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05366-w","article-title":"Bending forces and nucleotide state jointly regulate F-actin structure","volume":"611","author":"Reynolds","year":"2022","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"115321","DOI":"10.1016\/j.bcp.2022.115321","article-title":"A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology","volume":"206","author":"Eckenstaler","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.08.012","article-title":"Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility","volume":"301","author":"Wheeler","year":"2004","journal-title":"Exp Cell Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat Genet"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgm008","article-title":"Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR\/Vav2 signaling axis involved in cell invasion","volume":"28","author":"Patel","year":"2007","journal-title":"Carcinogenesis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2984","article-title":"Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma","volume":"46","author":"Kakiuchi","year":"2014","journal-title":"Nat Genet"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2174\/1574888x15666200330143958","article-title":"Current study of RhoA and associated signaling pathways in gastric cancer","volume":"15","author":"Liu","year":"2020","journal-title":"Curr Stem Cell Res Ther"},{"key":"B66","doi-asserted-by":"publisher","first-page":"17455","DOI":"10.1038\/s41598-021-96709-6","article-title":"The RhoA dependent anti-metastatic function of RKIP in breast cancer","volume":"11","author":"Kalpana","year":"2021","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2139\/ssrn.3854615","article-title":"TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA\/ROCK pathway","volume":"40","author":"Wei","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2023.151313","article-title":"RhoB as a tumor suppressor: It's all about localization","volume":"102","author":"Zaoui","year":"2023","journal-title":"Eur J Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12935-024-03519-7","article-title":"RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential","volume":"24","author":"Ning","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-03-0149","article-title":"Loss of RhoB expression in human lung cancer progression","volume":"10","author":"Mazieres","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22328","article-title":"RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line","volume":"120","author":"Sato","year":"2007","journal-title":"Int J Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25445","article-title":"A distinct role of RhoB in gastric cancer suppression","volume":"128","author":"Zhou","year":"2011","journal-title":"Int J Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.43101","article-title":"A high expression ratio of RhoA\/RhoB is associated with the migratory and invasive properties of basal-like breast tumors","volume":"17","author":"Privat","year":"2020","journal-title":"Int J Med Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200212049","article-title":"Activity of Rho-family GTPases during cell division as visualized with FRET-based probes","volume":"162","author":"Yoshizaki","year":"2003","journal-title":"J Cell Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/cells12030433","article-title":"RHOA therapeutic targeting in hematological cancers","volume":"12","author":"Santos","year":"2023","journal-title":"Cells"},{"key":"B76","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12964-023-01096-2","article-title":"Serotonin acts through YAP to promote cell proliferation: Mechanism and implication in colorectal cancer progression","volume":"21","author":"Yu","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-23-844","article-title":"Activation of RhoA\/ROCK2 signaling by hypoxia-inducible factor 1\u03b1 in promoting tumor growth and metastasis in human colon cancer","volume":"15","author":"Du","year":"2024","journal-title":"J Gastrointest Oncol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084160","article-title":"Impact of epithelial cell shedding on intestinal homeostasis","volume":"23","author":"Ngo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.05.011","article-title":"Epithelial defense against cancer (EDAC)","volume":"63","author":"Tanimura","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325520","article-title":"Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation","volume":"72","author":"Mart\u00ednez-S\u00e1nchez","year":"2023","journal-title":"Gut"},{"key":"B81","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1083\/jcb.200903079","article-title":"P115 RhoGEF and microtubules decide the direction apoptotic cells extrude from an epithelium","volume":"186","author":"Slattum","year":"2009","journal-title":"J Cell Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201010075","article-title":"Epithelial cell extrusion requires the sphingosine-1-phosphate receptor 2 pathway","volume":"193","author":"Gu","year":"2011","journal-title":"J Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.cub.2021.01.003","article-title":"Mechanotransduction activates RhoA in the neighbors of apoptotic epithelial cells to engage apical extrusion","volume":"31","author":"Duszyc","year":"2021","journal-title":"Curr Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.263786","article-title":"Epithelial cell extrusion at a glance","volume":"138","author":"Grata","year":"2025","journal-title":"J Cell Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201010001-01373","article-title":"Mind the gaps: confocal endomicroscopy showed increased density of small bowel epithelial gaps in inflammatory bowel disease","volume":"45","author":"Liu","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300695","article-title":"Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease","volume":"61","author":"Kiesslich","year":"2012","journal-title":"Gut"},{"key":"B87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/jb\/mvv050","article-title":"EDAC: Epithelial defence against cancer-cell competition between normal and transformed epithelial cells in mammals","volume":"158","author":"Kajita","year":"2015","journal-title":"J Biochem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e11-05-0469","article-title":"The tumor suppressor adenomatous polyposis coli controls the direction in which a cell extrudes from an epithelium","volume":"22","author":"Marshall","year":"2011","journal-title":"Mol Biol Cell"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fphy.2021.654613","article-title":"Mechanotransduction of strain regulates an invasive phenotype in newly transformed epithelial cells","volume":"9","author":"Chagnon-Lessard","year":"2021","journal-title":"Front Phys"},{"key":"B90","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41467-021-27896-z","article-title":"Matrix mechanics regulates epithelial defence against cancer by tuning dynamic localization of filamin","volume":"13","author":"Pothapragada","year":"2022","journal-title":"Nat Commun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2023.01.039","article-title":"Cell response to mechanical microenvironment cues via Rho signaling: From mechanobiology to mechanomedicine","volume":"159","author":"Xie","year":"2023","journal-title":"Acta Biomater"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1007\/s12672-025-03519-7","article-title":"Epithelial guardians against cancer: integrating cell competition and extrusion in early tumor control","volume":"16","author":"Riofrio-Chung","year":"2025","journal-title":"Discover Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/cm.21893","article-title":"A truncation mutant of adenomatous polyposis coli impairs apical cell extrusion through elevated epithelial tissue tension","volume":"82","author":"Gan","year":"2024","journal-title":"Cytoskeleton"},{"key":"B94","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.1038\/s41467-023-42774-6","article-title":"Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-kappaB-MMP21 pathway","volume":"14","author":"Nakai","year":"2023","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03525-z","article-title":"NOTUM from Apc-mutant cells biases clonal competition to initiate cancer","volume":"594","author":"Flanagan","year":"2021","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03558-4","article-title":"Apc-mutant cells act as supercompetitors in intestinal tumour initiation","volume":"594","author":"van Neerven","year":"2021","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03605-0","article-title":"Tracing oncogene-driven remodelling of the intestinal stem cell niche","volume":"594","author":"Yum","year":"2021","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e15-03-0161","article-title":"A role of the sphingosine-1-phosphate (S1P)\u2013S1P receptor 2 pathway in epithelial defense against cancer (EDAC)","volume":"27","author":"Yamamoto","year":"2016","journal-title":"Mol Biol Cell"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01045-6","article-title":"Epithelial cells remove precancerous cells by cell competition via MHC class I\u2013LILRB3 interaction","volume":"22","author":"Ayukawa","year":"2021","journal-title":"Nat Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcancer.2019.05.001","article-title":"Risk of colorectal cancer in inflammatory bowel diseases","volume":"64","author":"Nadeem","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/cancers13081882","article-title":"Cytoskeletal dynamics in epithelial-mesenchymal transition: insights into therapeutic targets for cancer metastasis","volume":"13","author":"Datta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29508","article-title":"Formin mDia1 contributes to migration and epithelial-mesenchymal transition of tubular epithelial cells exposed to TGF-\u03b21","volume":"121","author":"Li","year":"2020","journal-title":"J Cell Biochem"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1918167117","article-title":"The functional activity of E-cadherin controls tumor cell metastasis at multiple steps","volume":"117","author":"Na","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"jcs258767","DOI":"10.1242\/jcs.258767","article-title":"Enhanced RhoA signalling stabilizes E-cadherin in migrating epithelial monolayers","volume":"134","author":"Gupta","year":"2021","journal-title":"J Cell Sci"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405560121","article-title":"Regulation of intercellular viscosity by E-cadherin-dependent phosphorylation of EGFR in collective cell migration","volume":"121","author":"Fu","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2018.10.003","article-title":"Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells","volume":"1866","author":"Sousa-Squiavinato","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"dev.201898","DOI":"10.1242\/dev.201898","article-title":"RhoA GEF Mcf2lb regulates rosette integrity during collective cell migration","volume":"151","author":"Olson","year":"2024","journal-title":"Development"},{"key":"B108","article-title":"Upregulated STAT3 and RhoA signaling in colorectal cancer (CRC) regulate the invasion and migration of CRC cells","volume":"20","author":"Zhang","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.112174","article-title":"ROCK1 drives colorectal cancer liver metastasis via PRKCH-mediated bioenergetic reprogramming","volume":"138","author":"Luo","year":"2026","journal-title":"Cell Signal"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.066","article-title":"Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer","volume":"129","author":"Arango","year":"2005","journal-title":"Gastroenterology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-025-02533-1","article-title":"Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications","volume":"25","author":"Huang","year":"2025","journal-title":"Mol Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.377","article-title":"Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation","volume":"33","author":"Roh-Johnson","year":"2014","journal-title":"Oncogene"},{"key":"B113","doi-asserted-by":"publisher","first-page":"BSR20200265","DOI":"10.1042\/bsr20200265","article-title":"Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways","volume":"40","author":"Wan","year":"2020","journal-title":"Biosci Rep"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00328-2","article-title":"Claudin-1\/4 as directly target gene of HIF-1\u03b1 can feedback regulating HIF-1\u03b1 by PI3K-AKT-mTOR and impact the proliferation of esophageal squamous cell though Rho GTPase and p-JNK pathway","volume":"29","author":"Liu","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25572","article-title":"Wnt3A induces GSK-3\u03b2 phosphorylation and \u03b2-catenin accumulation through RhoA\/ROCK","volume":"232","author":"Kim","year":"2017","journal-title":"J Cell Physiol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.420","article-title":"Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer","volume":"118","author":"Dopeso","year":"2018","journal-title":"Br J Cancer"},{"key":"B117","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The Hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduction Targeted Ther"},{"key":"B118","doi-asserted-by":"publisher","first-page":"8916","DOI":"10.1038\/s41598-020-65772-w","article-title":"Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers","volume":"10","author":"Marx","year":"2020","journal-title":"Sci Rep"},{"key":"B119","doi-asserted-by":"publisher","first-page":"bgaf007","DOI":"10.1093\/carcin\/bgaf007","article-title":"Yes-associated protein plays oncogenic roles in human sporadic colorectal adenomas","volume":"46","author":"Fan","year":"2025","journal-title":"Carcinogenesis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.2174\/1568009621666211103113339","article-title":"The therapeutic potential of MAPK\/ERK inhibitors in the treatment of colorectal cancer","volume":"21","author":"Pashirzad","year":"2021","journal-title":"Curr Cancer Drug Targets"},{"key":"B121","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.yexcr.2005.11.019","article-title":"Deficient E-cadherin adhesion in C57BL\/6J-Min\/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility","volume":"312","author":"Carothers","year":"2006","journal-title":"Exp Cell Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2901006","article-title":"ARHGAP6 suppresses breast cancer tumor growth by promoting ferroptosis via rhoA-ROCK1-p38 MAPK signaling","volume":"29","author":"Chen","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.619069","article-title":"Intrinsic resistance of chronic lymphocytic leukemia cells to NK cell-mediated lysis can be overcome in vitro by pharmacological inhibition of Cdc42-induced actin cytoskeleton remodeling","volume":"12","author":"Wurzer","year":"2021","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"ra81","DOI":"10.1126\/scisignal.2001729","article-title":"A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse","volume":"4","author":"Carlin","year":"2011","journal-title":"Sci Signal"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.8.4195","article-title":"The Rac-activating toxin cytotoxic necrotizing factor 1 oversees NK cell-mediated activity by regulating the actin\/microtubule interplay","volume":"171","author":"Malorni","year":"2003","journal-title":"J Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41419-023-05949-z","article-title":"NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells","volume":"14","author":"Petillo","year":"2023","journal-title":"Cell Death Dis"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.4.2349","article-title":"Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics","volume":"177","author":"Graham","year":"2006","journal-title":"J Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12915-021-01068-3","article-title":"Rac1\/ROCK-driven membrane dynamics promote natural killer cell cytotoxicity via granzyme-induced necroptosis","volume":"19","author":"Zhu","year":"2021","journal-title":"BMC Biol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500676","article-title":"Control of homeostasis and dendritic cell survival by the GTPase RhoA","volume":"195","author":"Li","year":"2015","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/cells8070733","article-title":"RhoA as a key regulator of innate and adaptive immunity","volume":"8","author":"Bros","year":"2019","journal-title":"Cells"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14091","article-title":"Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway","volume":"110","author":"Long","year":"2019","journal-title":"Cancer Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m306079200","article-title":"Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling","volume":"278","author":"Tosello-Trampont","year":"2003","journal-title":"J Biol Chem"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-9822(01)00047-1","article-title":"Requirement for Rho GTPases and PI 3-kinases during apoptotic cell phagocytosis by macrophages","volume":"11","author":"Leverrier","year":"2001","journal-title":"Curr Biol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12974-021-02292-y","article-title":"Macrophage-specific RhoA knockout delays Wallerian degeneration after peripheral nerve injury in mice","volume":"18","author":"Xu","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.150987","article-title":"Rho\/ROCK pathway inhibition by the CDK inhibitor p27(kip1) participates in the onset of macrophage 3D-mesenchymal migration","volume":"127","author":"Gui","year":"2014","journal-title":"J Cell Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007505","article-title":"HIF2alpha is a direct regulator of neutrophil motility","volume":"137","author":"Sormendi","year":"2021","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.1.350","article-title":"Integrin regulation by RhoA in thymocytes","volume":"175","author":"Vielkind","year":"2005","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400839","article-title":"Gene targeting RhoA reveals its essential role in coordinating mitochondrial function and thymocyte development","volume":"193","author":"Zhang","year":"2014","journal-title":"J Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.7.903","article-title":"Analysis of thymocyte development reveals that the GTPase RhoA is a positive regulator of T cell receptor responses in vivo","volume":"194","author":"Corre","year":"2001","journal-title":"J Exp Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.05.004","article-title":"RhoA orchestrates glycolysis for TH2 cell differentiation and allergic airway inflammation","volume":"137","author":"Yang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.3a0119-025rrr","article-title":"Ablation of RhoA impairs Th17 cell differentiation and alleviates house dust mite-triggered allergic airway inflammation","volume":"106","author":"Yang","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726393","article-title":"Graded RhoA GTPase expression in Treg cells distinguishes tumor immunity from autoimmunity","volume":"12","author":"Kalim","year":"2021","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.07.007","article-title":"Inhibiting PGGT1B disrupts function of RHOA, resulting in T-cell expression of integrin alpha4beta7 and development of colitis in mice","volume":"157","author":"Lopez-Posadas","year":"2019","journal-title":"Gastroenterology"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033773","article-title":"RhoA of the Rho family small GTPases is essential for B lymphocyte development","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.842340","article-title":"The small GTPase RHOA links SLP65 activation to PTEN function in pre B cells and is essential for the generation and survival of normal and Malignant B cells","volume":"13","author":"Vadakumchery","year":"2022","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2551","article-title":"Promoter methylation of the DLC-1 gene and its inhibitory effect on human colon cancer","volume":"30","author":"Dai","year":"2013","journal-title":"Oncol Rep"},{"key":"B147","article-title":"Down-regualtion of miR-106b induces epithelial-mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer","volume":"8","author":"Zheng","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.269","article-title":"N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer","volume":"162","author":"Wang","year":"2022","journal-title":"Gastroenterology"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-10-2894","article-title":"p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase","volume":"71","author":"Yu","year":"2011","journal-title":"Cancer Res"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.266","article-title":"LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer","volume":"28","author":"Ong","year":"2009","journal-title":"Oncogene"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/181384","article-title":"Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression","volume":"2013","author":"Peng","year":"2013","journal-title":"BioMed Res Int"},{"key":"B152","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1038\/s41467-023-42228-z","article-title":"Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development","volume":"14","author":"Shimomura","year":"2023","journal-title":"Nat Commun"},{"key":"B153","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.7150\/thno.43427","article-title":"Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis","volume":"10","author":"Tian","year":"2020","journal-title":"Theranostics"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1967031","article-title":"Overexpression of GDP dissociation inhibitor 1 gene associates with the invasiveness and poor outcomes of colorectal cancer","volume":"12","author":"Xie","year":"2021","journal-title":"Bioengineered"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m111.337469","article-title":"RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility","volume":"287","author":"Yu","year":"2012","journal-title":"J Biol Chem"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0181-9","article-title":"RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach","volume":"32","author":"Hashimoto","year":"2019","journal-title":"Mod Pathol"},{"key":"B157","article-title":"ROCK I has more accurate prognostic value than MET in predicting patient survival in colorectal cancer","volume":"35","author":"Li","year":"2015","journal-title":"Anticancer Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-22-1170","article-title":"WNT5A-RHOA signaling is a driver of tumorigenesis and represents a therapeutically actionable vulnerability in small cell lung cancer","volume":"82","author":"Kim","year":"2022","journal-title":"Cancer Res"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.12.001","article-title":"Preclinical to clinical utility of ROCK inhibitors in cancer","volume":"9","author":"Barcelo","year":"2023","journal-title":"Trends Cancer"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-19-3984","article-title":"Cancer-associated point mutations in the DLC1 tumor suppressor and other Rho-GAPs occur frequently and are associated with decreased function","volume":"80","author":"Wang","year":"2020","journal-title":"Cancer Res"},{"key":"B161","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1002\/jcp.29402","article-title":"A tumor suppressor DLC1: The functions and signal pathways","volume":"235","author":"Zhang","year":"2020","journal-title":"J Cell Physiol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/ijms24044015","article-title":"The dual function of RhoGDI2 in immunity and cancer","volume":"24","author":"Tripathi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1021\/pr800271b","article-title":"Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer","volume":"7","author":"Zhao","year":"2008","journal-title":"J Proteome Res"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3247248\/v1","article-title":"Silencing GDI2 inhibits proliferation, migration and invasion of colorectal cancer through activation of p53 signaling pathway","volume":"10","author":"Ou","year":"2024","journal-title":"Heliyon"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.010595","article-title":"Rho kinases in health and disease: from basic science to translational research","volume":"67","author":"Loirand","year":"2015","journal-title":"Pharmacol Rev"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1080\/21541248.2017.1341366","article-title":"The ROCK isoforms differentially regulate the morphological characteristics of carcinoma cells","volume":"11","author":"Jerrell","year":"2020","journal-title":"Small GTPases"},{"key":"B167","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1038\/s41467-025-58810-6","article-title":"Synergistic immobilization of ions in mixed tin-lead and all-perovskite tandem solar cells","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"key":"B168","doi-asserted-by":"publisher","first-page":"16351","DOI":"10.1038\/s41598-019-52746-w","article-title":"Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling","volume":"9","author":"Kalpana","year":"2019","journal-title":"Sci Rep"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1964155","article-title":"Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA\/ROCK1\/LIMK1 signaling pathway","volume":"12","author":"Yan","year":"2021","journal-title":"Bioengineered"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13754","article-title":"Notch-1 regulates collective breast cancer cell migration by controlling intercellular junction and cytoskeletal organization","volume":"58","author":"Zhang","year":"2024","journal-title":"Cell Prolif"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-08-0248","article-title":"RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors","volume":"7","author":"Zhang","year":"2009","journal-title":"Mol Cancer Res"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2016.00041","article-title":"RhoA\/ROCK signaling regulates TGF\u03b2-induced epithelial-mesenchymal transition of lens epithelial cells through MRTF-A","volume":"22","author":"Korol","year":"2016","journal-title":"Mol Med"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157491","article-title":"A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma","volume":"8","author":"Lin","year":"2023","journal-title":"JCI Insight"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127923","article-title":"Loss of RhoA exacerbates, rather than dampens, oncogenic K-Ras induced lung adenoma formation in mice","volume":"10","author":"Zandvakili","year":"2015","journal-title":"PLoS One"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.07.026","article-title":"Hippo\/YAP, \u03b2-catenin, and the cancer cell: a \u201cm\u00e9nage \u00e0 trois\u201d in hepatoblastoma","volume":"147","author":"Sylvester","year":"2014","journal-title":"Gastroenterology"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201642455","article-title":"MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells","volume":"18","author":"Heidary Arash","year":"2017","journal-title":"EMBO Rep"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.09.029","article-title":"miR-802 suppresses acinar-to-ductal reprogramming during early pancreatitis and pancreatic carcinogenesis","volume":"162","author":"Ge","year":"2022","journal-title":"Gastroenterology"},{"key":"B178","article-title":"ROCK2 disturbs MKP1 expression to promote invasion and metastasis in hepatocellular carcinoma","volume":"10","author":"Du","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"3423692","DOI":"10.1155\/2022\/3423692","article-title":"Sonic Hedgehog promotes proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via Rho\/ROCK signaling","volume":"2022","author":"Hu","year":"2022","journal-title":"J Immunol Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-24-2801","article-title":"SMARCA4 inhibits breast cancer progression and metastasis through RHOA suppression","volume":"85","author":"Sun","year":"2025","journal-title":"Cancer Res"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091559","article-title":"The cytoskeleton effectors rho-kinase (ROCK) and mammalian diaphanous-related (mDia) formin have dynamic roles in tumor microtube formation in invasive glioblastoma cells","volume":"11","author":"Becker","year":"2022","journal-title":"Cells"},{"key":"B182","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","article-title":"Variegated RHOA mutations in adult T-cell leukemia\/lymphoma","volume":"127","author":"Nagata","year":"2016","journal-title":"Blood"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22202","article-title":"Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols","volume":"53","author":"Rohde","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.442","article-title":"Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the G\u03b113\/RhoA axis in B cells","volume":"35","author":"O'Hayre","year":"2016","journal-title":"Oncogene"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115120","article-title":"MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activity","volume":"44","author":"Boulton","year":"2025","journal-title":"Cell Rep"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2016.09.002","article-title":"Variegated RHOA mutations in human cancers","volume":"44","author":"Kataoka","year":"2016","journal-title":"Exp Hematol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.04.005","article-title":"RHOA takes the RHOad less traveled to cancer","volume":"8","author":"Schaefer","year":"2022","journal-title":"Trends Cancer"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19990531)81:5<682::aid-ijc2>3.0.co;2-b","article-title":"Rho GTPases are over-expressed in human tumors","volume":"81","author":"Fritz","year":"1999","journal-title":"Int J Cancer"},{"key":"B191","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2159-8290.cd-19-0811","article-title":"Gain-of-function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse gastric cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1126\/scisignaladg5289","article-title":"RHOA(L57V) drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling","volume":"16","author":"Schaefer","year":"2023","journal-title":"Sci Signal"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202400626","article-title":"RhoA and Rac1 as mechanotransduction mediators in colorectal cancer","volume":"9","author":"Yadav","year":"2025","journal-title":"Adv Biol (Weinh)"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.2174\/1389450111314100002","article-title":"Nuclear export mediated regulation of microRNAs: potential target for drug intervention","volume":"14","author":"Muqbil","year":"2013","journal-title":"Curr Drug Targets"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae190.0150","article-title":"DOP111 lack of epithelial RhoA in the gut, a new colitis-associated cancer experimental model","volume":"19","author":"Muccioli","year":"2025","journal-title":"J Crohn's Colitis"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.104","article-title":"Obesity suppresses cell-competition-mediated apical elimination of RasV12-transformed cells from epithelial tissues","volume":"23","author":"Sasaki","year":"2018","journal-title":"Cell Rep"},{"key":"B197","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42003-020-0847-y","article-title":"The COX-2\/PGE(2) pathway suppresses apical elimination of RasV12-transformed cells from epithelia","volume":"3","author":"Sato","year":"2020","journal-title":"Commun Biol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-023-01441-4","article-title":"Targeting small GTPases: Emerging grasps on previously untamable targets, pioneered by KRAS","volume":"8","author":"Yin","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70362","article-title":"Guanine nucleotide exchange factors and small GTPases: their regulation and functions, diseases, and therapeutic targets","volume":"6","author":"Lin","year":"2025","journal-title":"MedComm (2020)"},{"key":"B200","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41556-020-0488-x","article-title":"Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions","volume":"22","author":"Muller","year":"2020","journal-title":"Nat Cell Biol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201900585","article-title":"Targeting the small GTPase superfamily through their regulatory proteins","volume":"59","author":"Gray","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"B202","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.chembiol.2012.05.009","article-title":"Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases","volume":"19","author":"Shang","year":"2012","journal-title":"Chem Biol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1212324110","article-title":"Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors","volume":"110","author":"Shang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.08.017","article-title":"Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket","volume":"187","author":"Morstein","year":"2024","journal-title":"Cell"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c01034","article-title":"ZJK-807: a selective PROTAC degrader of KRAS(G12D) overcoming resistance in pancreatic cancer","volume":"68","author":"Liu","year":"2025","journal-title":"J Med Chem"},{"key":"B206","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/biom16020325","article-title":"Targeted protein degradation in cancer: PROTACs, new targets, and clinical mechanisms","volume":"16","author":"Faryal","year":"2026","journal-title":"Biomolecules"},{"key":"B207","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/biomedicines9010035","article-title":"Rhosin suppressed tumor cell metastasis through inhibition of Rho\/YAP pathway and expression of RHAMM and CXCR4 in melanoma and breast cancer cells","volume":"9","author":"Tsubaki","year":"2021","journal-title":"Biomedicines"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12963","article-title":"Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-020-0153-6","article-title":"Rational design of small molecule RHOA inhibitors for gastric cancer","volume":"20","author":"Kim","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/cancers14071604","article-title":"Second-generation JK-206 targets the oncogenic signal mediator RHOA in gastric cancer","volume":"14","author":"Beak","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-06-0782","article-title":"CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling","volume":"6","author":"Evelyn","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmbbm.2018.10.012","article-title":"Matrix stiffness regulates epithelial-mesenchymal transition via cytoskeletal remodeling and MRTF-A translocation in osteosarcoma cells","volume":"90","author":"Dai","year":"2019","journal-title":"J Mech Behav BioMed Mater"},{"key":"B213","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41232-020-00127-6","article-title":"Migration arrest of chemoresistant leukemia cells mediated by MRTF-SRF pathway","volume":"40","author":"Morimatsu","year":"2020","journal-title":"Inflammation Regener"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270288","article-title":"The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells","volume":"18","author":"Bachtler","year":"2023","journal-title":"PLoS One"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/s0026-895x(24)26508-1","article-title":"Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases","volume":"57","author":"Ishizaki","year":"2000","journal-title":"Mol Pharmacol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2005.06.015","article-title":"Development of specific Rho-kinase inhibitors and their clinical application","volume":"1754","author":"Tamura","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2009.05.002","article-title":"Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF","volume":"23","author":"Ding","year":"2009","journal-title":"Brain Behav Immun"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1177\/0271678x17718665","article-title":"Treatment with low dose fasudil for acute ischemic stroke in chronic hypertension","volume":"37","author":"Chan","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00156","article-title":"In vivo effects in melanoma of ROCK inhibition-induced FasL overexpression","volume":"5","author":"Teiti","year":"2015","journal-title":"Front Oncol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-20-0700","article-title":"First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors","volume":"26","author":"McLeod","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-13-1593","article-title":"Small-molecule intramimics of formin autoinhibition: a new strategy to target the cytoskeletal remodeling machinery in cancer cells","volume":"73","author":"Lash","year":"2013","journal-title":"Cancer Res"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00340","article-title":"Differential toxicity of mDia formin-directed functional agonists and antagonists in developing zebrafish","volume":"9","author":"LeCorgne","year":"2018","journal-title":"Front Pharmacol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.2174\/1568009616666151203224603","article-title":"Protein geranylgeranyltransferase type 1 as a target in cancer","volume":"16","author":"Ullah","year":"2016","journal-title":"Curr Cancer Drug Targets"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B225","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.27.5.1401","article-title":"HMG-CoA reductase inhibitors (statins) as anticancer drugs (review)","volume":"27","author":"Fritz","year":"2005","journal-title":"Int J Oncol"},{"key":"B227","article-title":"Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit","volume":"20","author":"Chae","year":"2015","journal-title":"Discov Med"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00516","article-title":"The innovative potential of statins in cancer: new targets for new therapies","volume":"8","author":"Di Bello","year":"2020","journal-title":"Front Chem"},{"key":"B229","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","article-title":"Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1alpha\/PPAR-gamma\/PKM2-mediated glycolysis","volume":"39","author":"Feng","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136242","article-title":"Stereospecific inhibitory effects of CCG-1423 on the cellular events mediated by myocardin-related transcription factor A","volume":"10","author":"Watanabe","year":"2015","journal-title":"PLoS One"},{"key":"B231","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1535-7163.mct-16-0482","article-title":"Pharmacological inhibition of myocardin-related transcription factor pathway blocks lung metastases of RhoC-overexpressing melanoma","volume":"16","author":"Haak","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010009","article-title":"Drug resistance in glioma cells induced by a mesenchymal-amoeboid migratory switch","volume":"20","author":"Ketchen","year":"2021","journal-title":"Biomedicines"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.04.080","article-title":"Optimization of novel nipecotic bis(amide) inhibitors of the Rho\/MKL1\/SRF transcriptional pathway as potential anti-metastasis agents","volume":"23","author":"Bell","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1128","article-title":"Rocks: multifunctional kinases in cell behaviour","volume":"4","author":"Riento","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-412","article-title":"The Rho-kinase inhibitor HA-1077 suppresses proliferation\/migration and induces apoptosis of urothelial cancer cells","volume":"14","author":"Abe","year":"2014","journal-title":"BMC Cancer"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-026-02490-7","article-title":"Subarachnoid hemorrhage: Clazosentan vs. Fasudil for vasospasm prevention (SAVIOR) study: study protocol for a prospective, multicenter, randomized trial","author":"Muraoka","year":"2026","journal-title":"Neurocrit Care"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024825","article-title":"Co-crystal structures of inhibitors with MRCKbeta, a key regulator of tumor cell invasion","volume":"6","author":"Heikkila","year":"2011","journal-title":"PLoS One"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260990","article-title":"Y-27632 acts beyond ROCK inhibition to maintain epidermal stem-like cells in culture","volume":"136","author":"Witkowski","year":"2023","journal-title":"J Cell Sci"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-7258(02)00191-2","article-title":"The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway","volume":"93","author":"Sasaki","year":"2002","journal-title":"Pharmacol Ther"},{"key":"B240","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/ph16020262","article-title":"Impact of vitamin D supplementation on the clinical outcomes and epigenetic markers in patients with acute coronary syndrome","volume":"16","author":"Sarhan","year":"2023","journal-title":"Pharm (Basel)"},{"key":"B241","doi-asserted-by":"publisher","first-page":"13350","DOI":"10.1038\/s41598-020-70378-3","article-title":"Rock inhibition promotes Na(V)1.5 sodium channel-dependent SW620 colon cancer cell invasiveness","volume":"10","author":"Poisson","year":"2020","journal-title":"Sci Rep"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899299","article-title":"ROCK2 inhibition triggers the collective invasion of colorectal adenocarcinomas","volume":"38","author":"Libanje","year":"2019","journal-title":"EMBO J"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09902-w","article-title":"K-Ras prenylation as a potential anticancer target","volume":"39","author":"Baranyi","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"B244","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/10409238.2019.1568964","article-title":"Inhibition of farnesyl pyrophosphate (FPP) and\/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers","volume":"54","author":"Waller","year":"2019","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.3390\/ijms23105424","article-title":"Protein prenyltransferases and their inhibitors: structural and functional characterization","volume":"23","author":"Marchwicka","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1188926","article-title":"New insights into the therapeutic potentials of statins in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"B247","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.3390\/cancers15194787","article-title":"Unraveling the anticancer potential of statins: Mechanisms and clinical significance","volume":"15","author":"Zaky","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111213","article-title":"Regulatory effects of statins on Akt signaling for prevention of cancers","volume":"120","author":"Hosseini","year":"2024","journal-title":"Cell Signal"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221075749","article-title":"Lovastatin inhibits RhoA to suppress canonical Wnt\/beta-catenin signaling and alternative Wnt-YAP\/TAZ signaling in colon cancer","volume":"31","author":"Xiao","year":"2022","journal-title":"Cell Transplant"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-08-0251","article-title":"RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells","volume":"6","author":"Doublier","year":"2008","journal-title":"Mol Cancer Res"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13548","article-title":"RhoA regulates resistance to irinotecan by regulating membrane transporter and apoptosis signaling in colorectal cancer","volume":"7","author":"Ruihua","year":"2016","journal-title":"Oncotarget"},{"key":"B252","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/s41467-022-34889-z","article-title":"Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer","volume":"13","author":"Adua","year":"2022","journal-title":"Nat Commun"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.2174\/1574892817666220325151555","article-title":"Knockdown of RhoA Expression Reverts Enzalutamide Resistance via the p38 MAPK Pathway in Castration-resistant Prostate Cancer","volume":"18","author":"Chen","year":"2023","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"B254","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13046-022-02354-w","article-title":"SEMA6A\/RhoA\/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF\/MEK inhibition in BRAF-mutant melanoma","volume":"41","author":"Loria","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.113956","article-title":"Inhibition of RhoGEF\/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma","volume":"436","author":"Zhou","year":"2024","journal-title":"Exp Cell Res"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17254","article-title":"HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer","volume":"26","author":"Xia","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B257","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","article-title":"An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells","volume":"53","author":"Kumagai","year":"2020","journal-title":"Immunity"},{"key":"B258","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/cells14030162","article-title":"Molecular mechanisms and clinical aspects of colitis-associated cancer in ulcerative colitis","volume":"14","author":"Yamamoto-Furusho","year":"2025","journal-title":"Cells"},{"key":"B259","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biocel.2017.10.009","article-title":"Rho-specific Guanine nucleotide exchange factors (Rho-GEFs) inhibition affects macrophage phenotype and disrupts Golgi complex","volume":"93","author":"Chen","year":"2017","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1844372\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:52Z","timestamp":1783575292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1844372\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":259,"alternative-id":["10.3389\/fimmu.2026.1844372"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1844372","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1844372"}}